TABLE 2 .

Assessment of Mycobacterium mungi infection in banded mongooses

Sample type (yr[s] of sample collection)	Results for M. mungi detection bya:
	PCRb			Histopathology
	% positive	No. of samples tested	% of positive samples in agreement with necropsy result (no. positive by necropsy)	% positive	No. of samples tested
Anal glands (2009–2015)	33	18	100	—c
Anal gland secretions (2009–2015)	39	44	100 (5)	—
Oral swabs (2009–2015)	53	19	100 (3)	—
Nasal swabs (2009–2015)	50	4	100 (1)	—
Nasal rinses (2015)	60	5	Status unknown
Urine (2011–2015)	22	23	60	NAd
Nasal planum (2000–2015)	29	52	69	35	34
Skin lesions (2003–2015)	100	7	100 (5)	56	9
Scrotum (2015)	100	2	100	—
Testicular lesions (2000–2008)	—			50	12
Lung (all disseminated disease) (2000–2012)	—			67	33
Bladder (2009–2015)	43	23	70	0	12
Kidney (2000–2012)	—			24	34
Feces (2013–2014)	0	113		NA
Other species feces (see text) (2013)	0	121		NA
Human feces in the environment (2012–2013)	0	12		NA
Soil from infected mongoose home ranges (2011 and 2014)	0	172		NA

^aThe prevalence of positive tissue samples is presented by assessment type and, of those positive, the percentage that came from individuals determined to be positive for M. mungi infection at necropsy.

^bIn PCR, samples were considered positive if primer sets for RD1^BCG, RD1^mic, RD1^seal, and RD1^mon amplified a PCR fragment of the expected size.

^c—, samples were not evaluated using the indicated diagnostic technique.

^dNA, Technique not used with this sample type.